Profile

Robert J. Applegate, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

116 Ratings
10 Comments
 

Robert J. Applegate, M.D.

Professor,

Clinical Interests

Angioplasty, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-7631

Insurance Accepted »

Media Medical Expert »

Related Links

Education & Training

  • B.A., University of California-Los Angeles, 1973
  • B.S., San Jose State University, 1976
  • M.D., University of Virginia School of Medicine, 1980
  • Internship, Medicine, Oregon Health Science Univ Sch, 1981
  • Residency, Medicine, Oregon Health Science Univ Sch, 1983
  • Fellowship, University of Texas Health Sci, 1984
  • Fellowship, University of Texas Health Sci, 1986

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Interventional Cardiology

Memberships

  • American College of Cardiology
  • Am Federation Of Clinical Rese
  • Aha - Council On Cardiology
  • Forsyth-Davie-Stokes Medical S

NPI Number

  • 1740265032
Robert J. Applegate, M.D.

Doctor Rating

4.7 out of 5

116 Ratings
10 Comments
 

Robert J. Applegate, M.D.

Professor, Cardiology

Research Interests

Drug-Eluting Stents; Myocardial Infarction; Coronary Artery Disease; Sirolimus; Paclitaxel
More »

Contact Information

Request An Appointment

Academic: 336-716-2718 | Department: 336-716-7631

Media Medical Expert »

Related Links

Recent Publications

Clinical outcomes in real-world patients with bifurcation lesions receiving Xience V everolimus-eluting stents: four-year results from the Xience V USA study. Hermiller JB, Applegate RJ, Baird C, Butler MM, Rutledge D, Wang J, Kakarala K, Krucoff MW, Sudhir K.. Catheter Cardiovasc Interv. 2016;88(1):62-70.

Unraveling the biological effects of drug-eluting stents [editorial]. Applegate RJ.. JACC Cardiovasc Interv. 2016;9(3):292-294.

Walking the tightrope between suppressing ischemia and minimizing bleeding [editorial comment]. Applegate RJ.. JACC Cardiovasc Interv. 2016;9(14):1484-1486.

Percutaneous coronary intervention for multivessel disease and ST-segment elevation myocardial infarction: when, not whether [editorial comment]. Applegate RJ.. JACC Cardiovasc Interv. 2016;9(17):1777-1779.

Retrograde percutaneous coronary intervention for chronic total occlusion: going backward to go forward [editorial comment]. Applegate RJ.. J Am Coll Cardiol. 2015;65(22):2401-2403.

Transcatheter aortic valve replacement customization based on paravalvular aortic regurgitation location [abstract]. Gilbert ON, Hermann DD, Alvarez L, Deutsch C, Aldrich A, Sacrinty M, Pu M, Stacey R, Applegate R, Gandhi S, Zhao D.. J Am Coll Cardiol. 2015;65(10 Suppl):A1791.

Allen's testing prior to transradial cardiac catheterization: state of the arch [editorial]. Sharma R, Applegate RJ.. J Invasive Cardiol. 2015;27(9):421-422.

Radial access for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: time for a paradigm shift? [editorial comment]. Applegate RJ.. J Am Coll Cardiol. 2014;63(10):973-975.

Conversations in cardiology: bridging antiplatelet therapy before surgery. Kern MJ, Applegate RJ, Bell M, Brilakis ES, Butman SM, Bach RG, Kaul P, Klein LW, Krucoff MW, Moore JA, Price MJ, Rao SV, Stone GW, Uretsky BF.. Catheter Cardiovasc Interv. 2014;83(5):748-752.

Minimizing femoral artery access complications during percutaneous coronary intervention: a comprehensive review. Lee MS, Applegate B, Rao SV, Kirtane A, Seto A, Stone GW.. Catheter Cardiovasc Interv. 2014;84(1):62-69.

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Raber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB.. JACC Cardiovasc Interv. 2014;7(10):1093-1102.

Gender differences in vascular complications associated with transfemoral and transradial cardiac catheterization and PCI: a single-center experience [abstract]. Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R.. J Am Coll Cardiol. 2013;61(10 Suppl):E77.

Cost effectiveness of Everolimus-eluting compared to propensity score matched bare metal stenting: an analysis of a selected stent strategy [abstract]. Applegate RJ, Sacrinty M, Gandhi S, Kutcher M, Santos R, Little W.. J Am Coll Cardiol. 2013;61(10 Suppl):E1505.

Peak troponin I greater than 5 times the 99th percentile after PCI does not define a high-risk group [abstract]. Butler M, Sacrinty M, Little W, Applegate R, Kutcher M, Santos R, Gandhi S.. J Am Coll Cardiol. 2013;61(10 Suppl):E1879.

The radial approach for STEMI: could this become the new standard of care? [magazine article]. Applegate RJ.. Cardiac Intervent Today. 2013;May/June():51-55.

Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years. Forrest JK, Lansky AJ, Meller SM, Hou L, Sood P, Applegate RJ, Wang JC, Skelding KA, Shah A, Kereiakes DJ, Sudhir K, Cristea E, Yaqub M, Stone GW.. Am J Cardiol. 2013;111(11):1580-1586.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, ten Berg JM, Brodie BR, Urban P, Jensen LO, Sardi G, Waksman R, Lasala JM, Schulz S, Stone GW, Airoldi F, Colombo A, Lemesle G, Applegate RJ,.. Int J Cardiol. 2013;167(2):575-584.

Conversation in cardiology: should FFR and IVUS be counted as PCI? [editorial]. Kern M, Applegate R, Bach RG, Bailey SR, Bashore TM, Bass TA, Bell M, de Bruyne B, Garratt KN, Jeremias A, Kereiakes DJ, Klein LW, Krucoff MW, Mintz GS, Morrison D, Ohman EM, Pichard A, Rosenfield K, Samady H, Stone GW,.. Catheter Cardiovasc Interv. 2013;82(1):110-115.

Second generation drug-eluting stents: a review of the everolimus-eluting platform. Whitbeck MG, Applegate RJ.. Clin Med Insights Cardiol. 2013;7():115-126.

Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W.. Catheter Cardiovasc Interv. 2013;82(4):E375-E384.

Costs of transradial percutaneous coronary intervention. Amin AP, House JA, Safley DM, Chhatriwalla AK, Giersiefen H, Bremer A, Hamon M, Baklanov DV, Aluko A, Wohns D, Mathias DW, Applegate RA, Cohen DJ, Marso SP.. J Am Coll Cardiol Intv. 2013;6(8):827-834.

Who is at risk to develop late drug-eluting stent thrombosis while on dual antiplatelet therapy? A subset analysis from the drug eluting stent event registry of thrombosis (DESERT) [abstract]. Waksman R, Torguson R, Kaneshige K, Kirtane A, Ryan T, Applegate R, Waxman S, Cohen D, Gordon P.. Eur Heart J. 2013;34(Suppl 1):551-552.

Minimizing complications following stent implantation: outcomes and follow-up. Douglas CJ, Applegate RJ.. Interv Cardiol. 2013;5(3):301-317.

The 'bladder sign'--an important early marker of retroperitoneal hemorrhage. Freilich MI, Gossman DE, Applegate RJ, Werns SW, Gips SJ, Turi ZG.. Catheter Cardiovasc Interv. 2012;79(1):158-165.

Drug-eluting stents versus bare metal stents in ST elevation myocardial infarction: from evidence to practice. Noureddine ND, Applegate RJ.. Minerva Cardioangiol. 2012;60(1):1-9.

Cost-effectiveness analysis of propensity matched radial and femoral cardiac catheterization and coronary intervention [abstract]. Schafer P, Sacrinty MT, Smith JW, Little W, Gandhi S, Kutcher M, Santos R, Smith T, Cecile AC, Applegate R.. J Am Coll Cardiol. 2012;59(13 Suppl):E72.

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials. Hermiller JB, Sudhir K, Applegate RJ, Rizvi A, Wang J, Gordon PC, Yaqub M, Cao S, Ferguson JM, Smith RS Jr, Sood P, Stone GW.. EuroIntervention. 2012;8(1):87-93.

Vascular closure device failure: we are getting better but not there yet [editorial comment]. Applegate RJ.. JACC Cardiovasc Interv. 2012;5(8):845-847.

Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. Lansky AJ, Brar SS, Yaqub M, Sood P, Applegate RJ, Lazar D, Jankovic I, Hermiller JB, Koo K, Sudhir K, Stone GW.. Am J Cardiol. 2012;110(1):21-29.

Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R.. Catheter Cardiovasc Interv. 2012;80(2):247-257.

Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state. Jollis JG, Al-Khalidi HR, Monk L, Roettig ML, Garvey JL, Aluko AO, Wilson BH, Applegate RJ, Mears G, Corbett CC, Granger CB.. Circulation. 2012;126(2):189-195.

Complex PCI in an elderly diabetic patient with advanced chronic kidney disease [clinical case update]. Butler MM, Applegate RJ.. Contrast-Induced Nephropathy Education. 2012;August():1-6.

Angiographic correlates of late and very late drug-eluting stent thrombosis: findings from the international multicenter Drug Eluting Stent Event Registry of Thrombosis (DESERT) [abstract]. Waksman R, Torguson R, Kaneshige K, Kirtane A, Ryan T, Raber L, Applegate R, Waxman S, Cohen D, Gordon P.. Eur Heart J. 2012;33(Suppl 1):389.

Contrast use and acute kidney injury in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Allem J, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B39-B40.

Cost effectiveness of Everolimus-eluting stents compared to first generation drug-eluting stents in contemporary clinical practice [abstract]. Applegate R, Sacrinty M, Gandhi S, Kutcher M, Santos R, Smith T, Little W.. J Am Coll Cardiol. 2012;60(17 Suppl B):B185.

Diastolic function at rest determines the prognosis of myocardial infarction [abstract]. Ohara T, Anzai T, Yasuda S, Ogawa H, Applegate R, Little W.. J Card Fail. 2012;18(10 Suppl 1):S190.

Drug-eluting stent event registry of thrombosis (DESERT): the International Drug-Eluting Stent Thrombosis Registry, angiographic assessment [abstract]. Waksman R, Torguson R, Kaneshige K, Kirtane A, Ryan T, Raber L, Applegate R, Waxman S, Cohen D, Gordon P.. J Am Coll Cardiol. 2012;60(17 Suppl):B180-B181.

Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Pervaiz MH, Sood P, Sudhir K, Hermiller JB, Hou L, Hattori K, Su X, Cao S, Wang J, Applegate RJ, Kereiakes DJ, Yaqub M, Stone GW, Cutlip DE.. Circ Cardiovasc Interv. 2012;5(2):150-156.

Femoral vascular access - approaches and available devices. Holland BH, Applegate RJ.. Interv Cardiol Rev. 2012;7(2):108-114.

Risk scoring systems for PCI: does one size fit all? [commentary]. Humphrey HL, Applegate RJ.. J Invasive Cardiol. 2011;23(2):70-71.

Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). Applegate RJ, Yaqub M, Hermiller JB, Sood P, Yu S, Doostzadeh J, Williams JE, Farhat N, Caputo R, Lansky AJ, et al.. Am J Cardiol. 2011;107(6):833-840.

Toward better stratification of patients with left main disease value of clinical and angiographic-derived risk scores [editorial comment]. Applegate RJ.. JACC Cardiovasc Interv. 2011;4(3):298-299.

Optimal therapy for ST-segment elevation myocardial infarction: the role of residual thrombus [editorial comment]. Applegate RJ.. J Am Coll Cardiol. 2011;57(19):1874-1876.

Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). Ng VG, Lansky AJ, Hermiller JB, Farhat N, Applegate RJ, Yaqub M, Sood P, Su X, Simonton CA, Sudhir K, et al.. Am J Cardiol. 2011;107(6):841-848.

Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, et al.. J Am Coll Cardiol. 2011;58(1):19-25.

Bleeding avoidance strategies: consensus and controversy. Dauerman HL, Rao SV, Resnic FS, Applegate RJ.. J Am Coll Cardiol. 2011;58(1):1-10.

Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ.. Circ Cardiovasc Qual Outcomes. 2011;4(4):408-415.

Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1057.

Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl 1):E1184.

Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ.. J Am Coll Cardiol. 2011;57(14 Suppl):E1269.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Cardiology

Clinical Interests

Angioplasty, Cardiac Catheterization, Cardiology (clinical), Cardiology (interventional)
Robert J. Applegate, M.D.

Robert J. Applegate, M.D.

Professor, Cardiology

Request An Appointment

Doctor Rating

4.7 out of 5

Robert J. Applegate, M.D.116 Ratings
10 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.5
Wait time at clinic
4.6



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/3/2016

*Dr. Applegate is very professional and I appreciate that -

5/27/2016

Very good.

5/26/2016

Dr Applegate is awesome! he has rtaken such good care of me and my husband. Good thing I don't have to go back for a year. Bad thing...I won't get to see Dr Applegate for a year . He is an incredibly smart and talented Doctor. I am hoping he stays at Baptist for a long time!

5/26/2016

Dr. Applegate is the best and I know that I am lucky to be his patient!!!

5/2/2016

Good.

4/29/2016

Good.

3/3/2016

Good experience.

1/7/2016

Very good.

10/14/2015

I think *Dr. Applegate is the best do. I ever had.

9/28/2015

Excellent provider, no bad experiences -

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.